Stakeholders weigh in on FDA’s draft clinical outcome assessment template
Regulatory NewsJoanne S. Eglovitch
Advertising, Promotion and LabelingPatient-focused drug developmentPharmaceuticalsProduct developmentRegulatory Intelligence/PolicyUnited StatesUS Food and Drug Administration (FDA)